Amniotic Products Market to grow USD 1.67 Billion by 2032, with compound annual growth rate 7.98%
Amniotic-derived products, sourced from the sac surrounding a developing foetus, are emerging as a potential treatment for joint issues. These products, including the amniotic membrane (the protective barrier) and amniotic fluid (the cushioning liquid), fall under the umbrella of orthobiologics, which utilize natural materials to promote healing. Initially used for treating skin conditions like burns and wounds due to their anti-inflammatory properties, amniotic-derived products are now being investigated for their ability to reduce inflammation and promote tissue repair in joints, potentially offering relief for conditions like arthritis. However, the excitement surrounding amniotic-derived products in orthopedics continues to grow.